Emergency Management of Elevated Intraocular Pressure in Cystic Fibrosis Patients
If tonometry indicates elevated IOP in a CF patient in an emergency setting, immediately perform gonioscopy to differentiate angle-closure from open-angle mechanisms, then initiate IOP-lowering therapy with topical medications while arranging urgent ophthalmology consultation, as CF patients may have baseline ocular abnormalities that complicate interpretation. 1
Immediate Assessment Algorithm
Step 1: Verify the IOP Measurement Accuracy
- Recognize that standard Goldmann applanation tonometry may be unreliable in CF patients who may have corneal abnormalities, including decreased tear film break-up time (present in 44% of CF patients) and potential corneal surface changes 2, 3
- If corneal edema or surface irregularity is present, use alternative tonometry methods such as pneumotonometer, rebound tonometry (iCare), or dynamic contour tonometer rather than relying solely on Goldmann readings 1, 4
- The pneumotonometer generates 40 readings per second and conforms to irregular corneal surfaces, making it preferable when corneal abnormalities are suspected 1, 4
Step 2: Perform Emergency Gonioscopy
- Gonioscopy is mandatory to determine if elevated IOP is due to angle-closure (requiring immediate intervention) versus open-angle mechanisms 1
- Perform compression gonioscopy with a four-mirror lens in a dark room using a bright, short beam that does not pass through the pupil to avoid inducing pupillary constriction 1
- Wait 10 seconds after lens placement to allow the pupil to resume its resting state, which may demonstrate pupillary block configuration 1
- If corneal edema impairs visualization, apply topical glycerin to clear the cornea 1
Step 3: Differentiate Acute Angle-Closure from Open-Angle Elevation
For Acute Angle-Closure Crisis (AACC):
- Look for conjunctival hyperemia, corneal edema (microcystic and stromal), mid-dilated or irregular pupil, and shallow anterior chamber 1
- Initiate immediate medical therapy with topical IOP-lowering agents and arrange for urgent laser peripheral iridotomy 1
- Avoid dilating the pupil, as this can precipitate or worsen angle-closure 1
For Open-Angle IOP Elevation:
- Measure IOP in both eyes using Goldmann applanation tonometry as the standard method 1
- Document baseline IOP, as elevated IOP is a major risk factor for glaucomatous progression 1
- Note that CF patients may have retinal nerve fiber layer thinning (particularly in the nasal-inferior quadrant), which could indicate pre-existing vulnerability to IOP-related damage 2, 5
CF-Specific Considerations
Ocular Manifestations in CF That Affect Emergency Management
- CF patients have significantly decreased inferior-quadrant peripapillary retinal nerve fiber layer thickness compared to controls, suggesting baseline vulnerability to optic nerve damage from elevated IOP 2
- Tear film abnormalities are common (56% of CF patients have abnormal tear break-up time), which may affect tonometry accuracy and require alternative measurement methods 2
- Visual field defects correlate with pulmonary function parameters (FEV1%, FVC%) and oxygen saturation, indicating that hypoxia may affect retinal ganglion cells 5
Systemic Factors Influencing Emergency Care
- Assess respiratory status including oxygen saturation, as CF patients with severe pulmonary disease may have compromised oxygenation affecting retinal function 5, 6
- CF patients may be on multiple medications and have complex medical histories requiring coordination with pulmonology 6
- Screen for pulmonary hypertension with transcutaneous oxygen saturation in the upright position, as portosystemic shunting complications can occur 1
Pharmacologic Management
Initial Medical Therapy for Elevated IOP
- For angle-closure crisis: Administer topical beta-blockers, alpha-agonists, and carbonic anhydrase inhibitors immediately 1
- For open-angle elevation: Initiate topical IOP-lowering therapy based on the degree of elevation and risk factors 1
- Consider intravenous acetazolamide 250-500 mg for rapid IOP reduction in acute cases, with subsequent dosing of 250 mg every 4 hours as needed 7
- The preferred acetazolamide dosage for acute glaucoma is 250 mg every 4 hours, though some acute cases may require an initial 500 mg dose followed by 125-250 mg every 4 hours 7
Critical Medication Considerations
- Avoid medications with anticholinergic or adrenergic effects (including ipratropium bromide and salbutamol-containing inhalers commonly used in CF) as these can precipitate angle-closure 1
- Acetazolamide interferes with theophylline assays and may produce increased urinary crystals, which is relevant given CF patients' complex medication regimens 7
Common Pitfalls and How to Avoid Them
Pitfall 1: Relying Solely on Goldmann Tonometry
- CF patients have ocular surface abnormalities that may render Goldmann readings inaccurate 2, 3
- Always consider alternative tonometry methods when corneal abnormalities are present 1, 4
Pitfall 2: Missing Angle-Closure Component
- Never assume open-angle mechanism without performing gonioscopy, as angle-closure requires fundamentally different emergency management 1
- Gonioscopy must be performed on both eyes, as the fellow eye is at risk 1
Pitfall 3: Inappropriate Pupil Dilation
- Dilation is contraindicated until angle-closure is ruled out by gonioscopy 1
- If fundus examination is essential before gonioscopy, attempt visualization using direct ophthalmoscopy, slit-lamp biomicroscopy with indirect lens, or non-mydriatic fundus photography 1
Pitfall 4: Underestimating Baseline Optic Nerve Vulnerability
- CF patients may have pre-existing retinal nerve fiber layer thinning and visual field defects related to chronic hypoxia 2, 5
- Set lower target IOP thresholds in CF patients with evidence of optic nerve compromise 1
Disposition and Follow-Up
Urgent Ophthalmology Consultation
- Arrange immediate ophthalmology consultation for any CF patient with IOP >21 mmHg or signs of angle-closure 1
- Document visual acuity, pupil examination, slit-lamp findings, IOP measurements, and gonioscopy results for the consulting ophthalmologist 1